Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-17-037014
Filing Date
2017-09-29
Accepted
2017-09-29 19:16:52
Documents
2
Period of Report
2017-09-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 3942
2 EXHIBIT 24.1. POWER OF ATTORNEY poa_oronsky.htm EX-24.1 5839
  Complete submission text file 0001140361-17-037014.txt   11509
Mailing Address C/O INTERWEST PARTNERS 2710 SAND HILL ROAD, SUITE 200 MENLO PARK CA 94025
Business Address
ORONSKY ARNOLD L (Reporting) CIK: 0001207833 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36830 | Film No.: 171112853

Mailing Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Issuer) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2834 Pharmaceutical Preparations